mardi 22 septembre 2020

MaveriX Oncology to Present at China Showcase 2020 and Biotech Showcase™ 2020 in San Francisco

Par Rédaction , dans Communiqués , le 13 janvier 2020

Monday, January 6th 2020 at 5:26pm UTC

Oncology, Inc
., a development-stage biotechnology company with a
proprietary pipeline of targeted small-molecule
chemo-immuno-therapeutics for the treatment of a broad range of solid
tumor and hematological malignancies, announces its attendance and
presentations at the China Showcase 2020 and Biotech Showcase™ 2020 in
San Francisco, California.

Dr. Steven A. Everett, President & CEO, will be presenting the Company
technology and investment opportunity at the showcases during the
following times:

China Showcase 2020:

Date: Sunday, January 12, 2020

Time: 4.15 PM (PST)

Location: Cyril Magnin III (4th floor), the Parc 55 Hotel

Biotech Showcase 2020:

Date: Tuesday, January 14, 2020

Time: 4.15 PM (PST)

Location: Franciscan B (Ballroom level), Hilton San Francisco Union

Dr. Steven A. Everett said “We are grateful to Demy-Colton and the EBD
Group for the opportunity to present our Company at the China Showcase
2020 and the Biotech Showcase 2020. These are ideal forums to engage
cross-border institutional or private investors and explore strategic
partnership opportunities. We encourage interested parties to attend our
presentations and/or request one-on-one meetings with our executive team
through the conference website and partneringONE® at”

“We are delighted that MaveriX Oncology, Inc., will be presenting at
Biotech Showcase this year,” said Sara Demy, CEO of Demy-Colton.
“Biotech Showcase is a prime occasion for global life science
entrepreneurs and investors to come together to discover the potential
for cross-border opportunities that will drive the future of drug


Biotech Showcase is an investor and networking conference devoted to
providing private and public biotechnology and life sciences companies
with an opportunity to present to, and meet with, investors and
pharmaceutical executives in one place. Investors and biopharmaceutical
executives from around the world gather in San Francisco during this
bellwether week which sets the tone for the coming year. Now in its 12th
year, this well-established, highly respected conference features
multiple tracks of presenting companies, plenary sessions, workshops,
networking, and an opportunity to schedule one-on-one meetings. Biotech
Showcase is produced by Demy-Colton and EBD Group. Both organizations
have a long history of producing high-quality programs that support the
biotechnology and broader life sciences industry.


MaveriX Oncology, Inc., is a globally orientated biotechnology company
focused on the discovery, development, and commercialization of targeted
small-molecule cancer chemo-immunotherapies. Our technology approach
leverages unexploited insights into cancer and immune cell metabolism
within the tumor microenvironment which are common to all cancers. Our
novel platform is designed to selectively deliver the tumor cell killing
benefits of chemotherapy while stimulating a robust immune response to
attack a wide range of cancers. Our experienced team is developing a
proprietary pipeline of drug candidates with the goal of bringing new
and improved treatments to patients suffering from cancer. For more
information about the company visit the website


Karen Sharma
Communications Representative
of MaveriX
Oncology, Inc.
Managing Director, MacDougall
T: +1(781)

Source: MaveriX Oncology, Inc.

Étiquettes : , , , , , , , , , ,